• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫检查点抑制剂(ICIs)相关眼肌炎。

Immune checkpoint inhibitors (ICIs)-related ocular myositis.

机构信息

Neuromuscular Disease Centre, Department of Neuroscience, Mental Health and Sensory Organs (NESMOS), SAPIENZA University of Rome, Sant'Andrea Hospital, Via di Grottarossa 1035-1039, 00189 Rome, Italy.

Department of Medical Oncology, San Camillo Forlanini Hospital, Rome, Italy.

出版信息

Neuromuscul Disord. 2020 May;30(5):420-423. doi: 10.1016/j.nmd.2020.02.013. Epub 2020 Feb 26.

DOI:10.1016/j.nmd.2020.02.013
PMID:32387281
Abstract

We present extensive clinical, serological, morphological and muscle imaging data of a 66-year-old man with isolated bilateral ptosis and external ophthalmoplegia secondary to Immune checkpoint inhibitors (Pembrolizumab). He had elevated CK level (>5000 UI/L). No facial, bulbar, proximal, distal or axial muscular weakness was observed. Electromyography (EMG) showed myopathic pattern, with spontaneous activity. Myositis specific antibodies and anti-striational antibodies were negative. Cardiac and respiratory functions were preserved. Skeletal muscle MRI was unremarkable, whereas extraocular muscles revealed bilateral hyperintensities in inferior rectus, medial rectus and superior oblique muscles in both T1 and STIR sequences, with mild muscle atrophy. Muscle biopsy showed endomysial inflammatory infiltrates, MHC-1 expression was observed in clusters of non-necrotic cells. CD56 positive cells were observed in perifascicular regions. Patient discontinued Pembrolizumab and received corticosteroid treatment with progressive clinical improvement and CK normalization. Our findings support this clinical entity, suggesting that isolated ocular myositis represents a subgroup of generalised myositis with predominant ocular symptoms.

摘要

我们呈现了一位 66 岁男性的广泛临床、血清学、形态学和肌肉影像学数据,他因免疫检查点抑制剂(Pembrolizumab)而出现孤立性双侧上睑下垂和外眼肌麻痹。他的 CK 水平升高(>5000 UI/L)。没有观察到面部、球部、近端、远端或轴性肌肉无力。肌电图(EMG)显示肌病模式,伴有自发性活动。肌炎特异性抗体和抗横纹肌抗体阴性。心脏和呼吸功能正常。骨骼肌 MRI 无明显异常,而眼外肌在 T1 和 STIR 序列中均显示下直肌、内直肌和上斜肌双侧高信号,伴有轻度肌肉萎缩。肌肉活检显示肌内膜炎症浸润,非坏死细胞簇中观察到 MHC-1 表达。在神经束旁区域观察到 CD56 阳性细胞。患者停用 Pembrolizumab 并接受皮质类固醇治疗,临床症状逐渐改善,CK 恢复正常。我们的发现支持这一临床实体,表明孤立性眼肌炎代表以眼部症状为主的全身性肌炎的一个亚组。

相似文献

1
Immune checkpoint inhibitors (ICIs)-related ocular myositis.免疫检查点抑制剂(ICIs)相关眼肌炎。
Neuromuscul Disord. 2020 May;30(5):420-423. doi: 10.1016/j.nmd.2020.02.013. Epub 2020 Feb 26.
2
Pembrolizumab-related systemic myositis involving ocular and hindneck muscles resembling myasthenic gravis: a case report.帕博利珠单抗相关的全身性肌炎累及眼肌和颈后肌,类似于重症肌无力:病例报告。
BMC Neurol. 2019 Aug 5;19(1):184. doi: 10.1186/s12883-019-1416-1.
3
Checkpoint inhibitor myasthenia-like syndrome and myositis associated with extraocular muscle atrophy.与眼外肌萎缩相关的免疫检查点抑制剂相关肌无力样综合征和肌炎。
J Clin Neurosci. 2020 Jan;71:271-272. doi: 10.1016/j.jocn.2019.11.038. Epub 2019 Dec 27.
4
A Fatal Case of Myocarditis Following Myositis Induced by Pembrolizumab Treatment for Metastatic Upper Urinary Tract Urothelial Carcinoma.帕博利珠单抗治疗转移性上尿路尿路上皮癌诱发肌炎后发生心肌炎致死一例
Int Heart J. 2020 Sep 29;61(5):1070-1074. doi: 10.1536/ihj.20-162. Epub 2020 Sep 12.
5
[A case of myasthenia gravis and myositis induced by pembrolizumab].[一例由帕博利珠单抗诱发的重症肌无力和肌炎病例]
Rinsho Shinkeigaku. 2019 Aug 29;59(8):502-508. doi: 10.5692/clinicalneurol.cn-001251. Epub 2019 Jul 23.
6
Myositis as an adverse event of immune checkpoint blockade for cancer therapy.癌症免疫治疗的免疫检查点阻断的不良反应:肌炎。
Semin Arthritis Rheum. 2019 Feb;48(4):736-740. doi: 10.1016/j.semarthrit.2018.05.006. Epub 2018 May 18.
7
Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series.免疫检查点抑制剂相关肌炎和心肌炎:真实世界、机构病例系列中的诊断陷阱和影像学贡献。
J Neurol. 2024 Apr;271(4):1947-1958. doi: 10.1007/s00415-023-12134-x. Epub 2023 Dec 23.
8
Pembrolizumab and epacadostat induced fatal myocarditis and myositis presenting as a case of ptosis and ophthalmoplegia.帕博利珠单抗和依帕司他导致致命性心肌炎和肌炎,表现为一例上睑下垂和眼肌麻痹。
Orbit. 2019 Jun;38(3):244-247. doi: 10.1080/01676830.2018.1490439. Epub 2018 Jul 9.
9
Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer.癌症患者的免疫检查点抑制剂相关肌炎和心肌炎。
Neurology. 2018 Sep 4;91(10):e985-e994. doi: 10.1212/WNL.0000000000006124. Epub 2018 Aug 8.
10
Pembrolizumab-induced Ocular Myasthenia Gravis with Anti-titin Antibody and Necrotizing Myopathy.帕博利珠单抗诱导的伴抗肌联蛋白抗体和坏死性肌病的眼肌型重症肌无力
Intern Med. 2019 Jun 1;58(11):1635-1638. doi: 10.2169/internalmedicine.1956-18. Epub 2019 Feb 1.

引用本文的文献

1
Immune Checkpoint Inhibitor Myopathy: The Double-Edged Sword of Cancer Immunotherapy.免疫检查点抑制剂相关性肌病:癌症免疫治疗的双刃剑。
Neurology. 2024 Dec 10;103(11):e210031. doi: 10.1212/WNL.0000000000210031. Epub 2024 Nov 8.
2
Immune Checkpoints and Graves' Disease, Thyroid Eye Disease, and Orbital Myopathy: A Comprehensive Review.免疫检查点与格雷夫斯病、甲状腺眼病和眼眶肌病:综述
J Ophthalmic Vis Res. 2024 Sep 16;19(3):368-380. doi: 10.18502/jovr.v19i3.15047. eCollection 2024 Jul-Sep.
3
Tuberculosis reactivation demonstrated by choroiditis and inflammatory choroidal neovascular membrane in a patient treated with immune checkpoint inhibitors for malignant mucosal melanoma.
一名接受免疫检查点抑制剂治疗恶性黏膜黑色素瘤的患者,出现脉络膜炎和炎性脉络膜新生血管膜,提示结核病复发。
J Ophthalmic Inflamm Infect. 2023 Dec 18;13(1):54. doi: 10.1186/s12348-023-00374-x.
4
Ocular adverse events associated with immune checkpoint inhibitors, a scoping review.与免疫检查点抑制剂相关的眼部不良事件:一项范围综述
J Ophthalmic Inflamm Infect. 2023 Feb 22;13(1):5. doi: 10.1186/s12348-022-00321-2.
5
Myasthenia Gravis in the Setting of Immune Checkpoint Inhibitor Therapy: Practical Considerations and Opinion-Based Approach to Acute Management.免疫检查点抑制剂治疗背景下的重症肌无力:急性管理的实践考量与基于观点的方法
Cureus. 2022 Oct 24;14(10):e30638. doi: 10.7759/cureus.30638. eCollection 2022 Oct.
6
A Challenging Case of Eyelid Ptosis and Diplopia Induced by Pembrolizumab.一例由帕博利珠单抗引起的眼睑下垂和复视的挑战性病例。
Cureus. 2022 Aug 24;14(8):e28330. doi: 10.7759/cureus.28330. eCollection 2022 Aug.
7
Concurrent Ocular Myopathy and Myasthenia Gravis After Zimberelimab Therapy in a Patient With Non-Small-Cell Lung Cancer.一名非小细胞肺癌患者接受zimberelimab治疗后并发眼肌病和重症肌无力
J Clin Neurol. 2022 May;18(3):364-366. doi: 10.3988/jcn.2022.18.3.364.
8
Immune checkpoint inhibitor-associated ophthalmic adverse events: current understanding of its mechanisms, diagnosis, and management.免疫检查点抑制剂相关的眼部不良事件:对其机制、诊断和管理的当前认识
Int J Ophthalmol. 2022 Apr 18;15(4):646-656. doi: 10.18240/ijo.2022.04.19. eCollection 2022.
9
Case Report: The Neuromusclar Triad of Immune Checkpoint Inhibitors: A Case Report of Myositis, Myocarditis, and Myasthenia Gravis Overlap Following Toripalimab Treatment.病例报告:免疫检查点抑制剂的神经肌肉三联征:托匹单抗治疗后肌炎、心肌炎和重症肌无力重叠的病例报告
Front Cardiovasc Med. 2021 Aug 16;8:714460. doi: 10.3389/fcvm.2021.714460. eCollection 2021.
10
Ocular Toxicity of Targeted Anticancer Agents.靶向抗癌药物的眼部毒性。
Drugs. 2021 May;81(7):771-823. doi: 10.1007/s40265-021-01507-z. Epub 2021 Mar 31.